Post-chemotherapy laparoscopic retroperitoneal lymph-node dissection in testis cancer patients

Journal of Endourology

Volumn 21, Issue 12, 2007, Pages 1501-1504

  Maldonado Valadez, Rafael ^a   Schilling, David ^a   Anastasiadis, Aristotelis G ^a   Sturm, Wolfgang ^a   Stenzl, Arnulf ^a   Corvin, Stefan ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Urologische Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HUMAN; IMAGE ANALYSIS; INTERSTITIAL PNEUMONIA; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; MALE; MINIMAL RESIDUAL DISEASE; MULTIPLE CYCLE TREATMENT; OPERATION DURATION; OUTCOME ASSESSMENT; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; SAFETY; TESTIS CANCER; TUMOR VOLUME;

ADULT; ANTINEOPLASTIC AGENTS; CARCINOMA; FOLLOW-UP STUDIES; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RETROPERITONEAL SPACE; RETROSPECTIVE STUDIES; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 38049178568     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2006.0441     Document Type: Article

References (13)

1. Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP. Complications of post-chemotherapy retroperitoneal lymph node dissection. J Urol 1995;153:976-980.
2. Rukstalis DB, Chodak GW. Laparoscopic retroperitoneal lymph node dissection in a patient with stage I testicular carcinoma. J Urol 1992;148:1907-1910.
3. Rassweiler JJ, Seemann O, Henkel TO, Stock C, Frede T, Alken P. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: Indications and limitations. J Urol 1996;156:1108-1113.
4. Corvin S, Sturm W, Kuczyk M, Anastasiadis AG, Stenzl A. Laparoscopic retroperitoneal lymphadenectomy in the management of low-stage testicular cancer: Technique and results. Minim Invasive Ther Allied Technol 2005;14:52-56.
5. Janetschek G, Hobisch A, Höltl L, Bartsch G. Retroperitoneal lymphadenectomy for clinical stage I nonseminomatous testicular tumor: Laparoscopy versus open surgery and impact of learning curve. J Urol 1996;156:89-93.
6. Janetschek G. Laparoscopic retroperitoneal lymph node dissection. Urol Clin North Am 2001;28:107-114.
7. Steiner H, Peschel R, Janetschek G, Höltl L, Berger AP, Bartsch G, Hobisch A. Long-term results of laparoscopic retroperitoneal lymph node dissection: A single-center 10-year experience. Urology 2004;63:550-555.
8. Janetschek G, Hobisch A, Hittmair A, Höltl L, Peschel R, Bartsch G. Laparoscopic retroperitoneal lymphadenectomy after chemotherapy for stage IIB nonseminomatous testicular carcinoma. J Urol 1999;161:477-481.
9. Palese MA, Su LM, Kavoussi LR. Laparoscopic retroperitoneal lymph node dissection after chemotherapy. Urology 2002;60:130-134.
10. Weissbach L, Boedefeld E. Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I. J Urol 1987;138:77-82.
11. Mosharafa AA, Foster RS, Koch MO, Bihrle R, Donohue JP. Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol 2004;171:1839-1841.
12. Tognini PG, Foster RS, McGraw P, et al. Combined postchemotherapy retroperitoneal lymph node dissection and resection of chest tumor under the same anesthetic is appropriate based on the morbidity and tumor pathology. J Urol 1998;159:1833-1835.
13. Rabbani F, Goldenberg SL, Gleave ME, Paterson RF, Murray N, Sullivan LD. Retroperitoneal lymphadenectomy for post-chemotherapy residual masses: Is a modified dissection and resection of residual masses sufficient? Br J Urol 1998;81:295-300.